Revvity, Inc. (FRA:PKN)

Market Cap	10.44B
Revenue (ttm)	2.56B
Net Income (ttm)	264.60M
Shares Out	n/a
EPS (ttm)	2.17
PE Ratio	39.46
Forward PE	19.26
Dividend	0.26 (0.32%)
Ex-Dividend Date	Jul 18, 2025

Volume	n/a
Average Volume	12
Open	87.56
Previous Close	81.34
Day's Range	86.94 - 87.56
52-Week Range	77.00 - 121.05
Beta	n/a
RSI	53.09
Earnings Date	Jul 31, 2025

About Revvity

Revvity, Inc. provides health sciences solutions, technologies, and services worldwide. The company’s Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and DNA sequencing services. Its Diagnostics segment offers instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for tes...

• Industry: Laboratory Analytical Instruments
• Founded: 1937
• Employees: 11,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PKN

Financial Performance

In 2024, Revvity's revenue was $2.76 billion, an increase of 0.16% compared to the previous year's $2.75 billion. Earnings were $270.39 million, a decrease of -60.99%.

Financial numbers in USD